These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23769111)

  • 21. [Major surgery on Jehovah's Witnesses].
    Høiseth LØ; Giercksky KE; Larsen SG; Kongsgaard U
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2658-61. PubMed ID: 17057765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac surgery in Jehovah's Witnesses. Experience in Santander, Spain].
    Bernal JM; Naranjo S; Trugeda M; Sarralde A; Diago C; Revuelta JM
    Rev Esp Cardiol; 2006 May; 59(5):507-9. PubMed ID: 16750149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-institution experience of performing bloodless transplant in Jehovah's Witness patients.
    Coltoff A; Shreenivas A; Afshar S; Steinberg A
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):44-49. PubMed ID: 30605629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of life-threatening epistaxis in a Jehovah's Witness.
    Stark RD; Coatesworth AP; Tucker AG
    Int J Clin Pract; 2003; 57(1):60-1. PubMed ID: 12587946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thoracic and cardiovascular surgery in Jehovah's Witness].
    Furuya O; Higashiue S; Matsubayashi K; Tonda H; Kawahira T; Azuma S; Komooka M; Hiramatsu N
    Kyobu Geka; 2012 Dec; 65(13):1119-22. PubMed ID: 23202705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation in Jehovah's Witnesses patients in a center of northeastern Brazil.
    Garcia JH; Coelho GR; Feitosa Neto BA; Nogueira EA; Teixeira CC; Mesquita DF
    Arq Gastroenterol; 2013 Apr; 50(2):138-40. PubMed ID: 23903624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ENT surgery, blood and Jehovah's Witnesses.
    Woolley SL; Smith DR
    J Laryngol Otol; 2007 May; 121(5):409-14. PubMed ID: 17125571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral sequential lung transplantation in Jehovah's Witnesses.
    Chan EG; Morrell MR; Chan PG; Sanchez PG
    Perfusion; 2021 Oct; 36(7):672-676. PubMed ID: 32650703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.
    Chigbu B; Onwere S; Kamanu C; Aluka C; Okoro O; Feyi-Waboso P; Onichakwe C
    Arch Gynecol Obstet; 2009 Apr; 279(4):469-72. PubMed ID: 18677500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful use of ECMO in a Jehovah's Witness after complicated re-heart transplant.
    Russo MJ; Merlo A; Eton D; Patel PJ; Fedson S; Anderson A; Shah A; Jeevanandam V
    ASAIO J; 2013; 59(5):528-9. PubMed ID: 23995995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical strategies in the medical care of Jehovah's Witnesses.
    Remmers PA; Speer AJ
    Am J Med; 2006 Dec; 119(12):1013-8. PubMed ID: 17145240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beriplex P/N: an alternative to fresh frozen plasma in severe haemorrhage.
    Bhardwaj M; Bunsell R
    Anaesthesia; 2007 Aug; 62(8):832-4. PubMed ID: 17635434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
    Zhou L; Mohsen A; Khan MA; Guthrie T
    J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart transplantation in Jehovah's Witnesses. An initial experience and follow-up.
    Burnett CM; Duncan JM; Vega JD; Lonquist JL; Sweeney MS; Frazier OH
    Arch Surg; 1990 Nov; 125(11):1430-3. PubMed ID: 2241551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of death for Jehovah's Witnesses after major trauma.
    Varela JE; Gomez-Marin O; Fleming LE; Cohn SM
    J Trauma; 2003 May; 54(5):967-72. PubMed ID: 12777911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.
    Bolliger D; Sreeram G; Duncan A; Molinaro RJ; Szlam F; Chen EP; Tanaka KA
    Ann Thorac Surg; 2009 Nov; 88(5):1666-8. PubMed ID: 19853132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report.
    Tenenbaum T; Hasan C; Kramm CM; Janssen G; Laws HJ; Wessalowski R; Bode U; Göbel U
    Onkologie; 2004 Apr; 27(2):131-7. PubMed ID: 15138344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of a Jehovah's Witness with thrombotic thrombocytopenic purpura without using plasma: A case report and review of the literature.
    Baseri B; Vishwanathan S; Benasher D; Khazan M; Luhrs C; Tsai HM
    J Clin Apher; 2019 Oct; 34(5):623-630. PubMed ID: 31116457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.